Research

Pharmaceutical Sciences

Title :

Exploration of Cyclic Diaryliodonium Salts as Biarylating Agents to Generate Medicinally Relevant Biaryl

Area of research :

Pharmaceutical Sciences

Focus area :

Organic Chemistry, Medicinal Chemistry

Principal Investigator :

Dr. Malleswara Rao Kuram, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh

Timeline Start Year :

2024

Timeline End Year :

2027

Contact info :

Details

Executive Summary :

Innovations in chemical synthesis plays a crucial role in drug discovery and development. In particular, rapid and easy access to unattainable diversifications of medicinally relevant molecular scaffolds, accelerate and increase the success of pharmaceutical research. The biaryl moiety containing substructures are known to show dominant interactions with aromatic and hydrophobic residues with numerous binding sites. Consequently, the biaryl moiety is prevalent in many pharmaceuticals. Therefore, easy access to the construction of novel biaryl scaffolds with hitherto unprecedented functionalization patterns is highly desirable to generate novel NCEs for drug discovery research. The cyclic diaryliodonium salts have the potential to expand the chemical space for drug discovery by the direct construction of biaryl moiety with additional iodo functionality for further modification. However, the biaryltion of unactivated C(sp3)-H bond functionalization and bifunctionalization of cyclic diaryliodonium salts is still in its infancy. Thus, in this project, metal catalyzed bifunctionalization of cyclic diaryliodonium salts will be investigated to develop efficient protocols to access various biaryl derivatives decorated with multiple functionalizations. The developed synthetic protocols will be employed to prepare a library of privileged biaryl derivatives and subsequently will be evaluated for their biological activities particularly as antimicrobials.

Total Budget (INR):

40,11,724

Organizations involved